Voyager Therapeutics, Inc.

VT6.F·Frankfurt·Healthcare
Compare
1.5800+0.0330 (+2.13%)today
As of Nov 5, 9:09 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.5470
Open1.5800
Day range—
52-week range1.47004.3780
Off day high0.00%
Off 52-week high−63.91%
Volume500
Avg. volume (3M)37.00
Market cap97.36M
EPS (TTM)-1.51
Forward P/E-0.66
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.17
Shares outstanding61.62M
Short interest—
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin0.00%

Latest news

All VT6.F news ›
markets.businessinsider.com·Positive

Voyager Therapeutics (VYGR) Gets a Buy from Wells Fargo

In a report released on October 2, from Wells Fargo maintained a Buy rating on Voyager Therapeutics, with a price target of $10.00. The company... In a report released on October 2, from Wells Fargo maintained a Buy rating on Voyager…

markets.businessinsider.com·Positive

TD Cowen Remains a Buy on Voyager Therapeutics (VYGR)

TD Cowen analyst Phil Nadeau maintained a Buy rating on Voyager Therapeutics yesterday. The company’s shares closed yesterday at $3.13. Nadeau covers the Healthcare sector, focusing on stocks such as Biogen, Voyager Therapeutics, and…

From the 4Search news index, newest first.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance